Fakta leverer revisjon og utvidede regnskap- og rådgivningstjenester. Vi holder til i Solheimsviken 15B, Beddingen på Danmarksplass. Vår filosofi er å være et frittstående, lokalt selskap som leverer høy kvalitet med spisskompetanse som du kan stole på.I Fakta er vi opptatt av å ha nærhet til våre kunder på Vestlandet. Lokal forankring og uavhengighet gir oss i mange tilfeller muligheten til å tilby tjenester til en mer konkurransedyktig pris. Vi har oppdragsgivere innen et stort spekter av norsk næringsliv, og vi dekker behovene til mindre bedrifter så vel som større, børsnoterte selskaper.Etter betydelig vekst er vi nå ca 26 meget kompetente fagpersoner. For å holde tritt med utviklingen er våre tjenester i kontinuerlig utvikling og forbedring. Dette gjør oss til den aktive sparringspartneren du kan diskutere løsninger med og som gir deg gode råd når du trenger det.

OptoScale supplies fish farmers with precise and relevant data empowering them to make decision that improve productivity, sustainability, and animal welfare. Our data informs fish farmers about how their production is going, by accurately measuring the size of fish, growth, welfare status, and parasite counting. Our head office is in Trondheim, Norway, and we deliver to our great customers around the world. We are continuously interested in hiring great people across most of our functions: HW development, AI/ML, electronics, sales and customer success.

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

Yetz is a new distribution platform for product lines such as insurance, electricity, telecom, and finance. At launch, we will offer both insurance and power. We utilize strong incentives towards our customers and partners to share the concept, by giving them an affiliate commission. Monthly payment is based on the turnover of customers they have referred. Two fully owned sister companies Yetz Strøm og Yetz Forsikring.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

The Norgeskart app for iPhone and iPad is the most detailed map of Norway. Norgeskart is suitable for hikers, tourists, and city walkers. • Comprehensive, accurate maps of Norway are delivered by Kartverket • Download the map for offline use • GPS navigation with auto-rotating map and compass • Search for places and addresses • Detailed trails for hiking, biking, and walking • Accurate sea maps along the Norwegian coast • Ad-free experience

ICT is a Norwegian technology development company that holds patents designed to bring new opportunities to the cryogenic liquids storage and transportation sectors via unique containers. The design targets the market for both large- and small-scale cryogenic applications. ICT’s solution is modular and suited for onshore as well as maritime use. The development of hydrogen infrastructure is slow and holding back widespread adoption. Transportation of large volumes is one of the major challenges that IC Technologies is determined to solve. Another challenge is the storage of liquid hydrogen. Current storage solutions resemble enlarged thermos flasks, and the hydrogen inside gradually evaporates over time. Our vision is a decarbonized world with green hydrogen as a major energy carrier.

Urban Infrastructure Partner is a Norwegian based mobility operator and in 2016  we launched a new kind of bike sharing- Oslo City Bike, which has more than doubled usage in less than 8 months. In Oslo we’ve now reached more than 2 million trips and increased the utilization to 10 trips per bike per day. But most importantly - we make mobility more efficient and easier for a lot of people every day.We believe success for a smart city and systems like ours should not be measured by it's mere existence, but on the actual effect it has for the city.Read more about how it is to work with us here https://oslobysykkel.no/ansatte

VENTURE FACTORYVenture Factory was founded in the fall of 2012 in Oslo, Norway with a straightforward goal: turning ideas into business. Our core competence is e-commerce, technology, and performance marketing. We use our skills to start new companies together with strategic partners, other entrepreneurs, or within our own organization. Since then we’ve involved ourselves in a range of ideas. Some have blossomed and turned into prosperous businesses, while others have been challenging and ultimately put to rest. We believe our understanding of technology and online marketing combined with a unique domain insight is the recipe for success and therefore we partner up with entrepreneurs or larger corporations to pursue new business opportunities. Our portfolio consists of a mix of businesses. Some are consultancies where external clients benefit from our competence and others are tech or e-commerce ventures that we have started alone or together with partners. Do you have a great idea you want to discuss with us? Please email us at contact@venturefactory.noVenture Factory offices are located centrally in Oslo and our development team is located in Odesa, Ukraine. We are always on the lookout for great talent both in Odessa and Oslo, so email us at contact@venturefactory.no if you think you are a good match.

Bookd AS ble etablert i 2021 og jobber med å forenkle bookingprosesser i underholdningsbransjen. Vårt fokus er å tilby underholdning på en enkel og intuitiv måte til bedrifts- og privatarrangementer. Vi har utviklet en app (iOS) hvor man kan finne og booke underholdning på en enkel måte. Vi tilbyr artister, DJs, komikere, foredragsholdere, dansere, kokker og annen underholdning som passer til ulike typer arrangementer. I 2022 er målet å etablere seg i Norge før vi skal skalere videre til nye markeder.Vi har en stor profilbase, samt gode og etablerte partnerskap med flere av Norges største eventbyråer og bedrifter.

Bytt.no er Norges største sammenligningstjeneste for tjenester og produkter innen personlig økonomi. Hver dag bruker tusenvis av nordmenn Bytt.no for å lese verifiserte brukeromtaler om selskaper og sammenligne priser på tusenvis av tjenester og produkter. Vi er en rendyrket IT-bedrift innen fintech og insurtech som digger å løse problemer ved hjelp av ny teknologi. Vårt primære mål er å koble nye kunder med gode bedrifter. Vi jobber med å forenkle, tilgjengeliggjøre og sammenligne tradisjonelt gammeldagse og lite transparente bransjer ved hjelp av teknologi og smarte løsninger. Lyst til å jobbe med oss? Vi har ledige stillinger, sjekk: www.bytt.no/jobb

Exabel is an artificial intelligence startup based in Oslo, Norway. Exabel’s mission is to synthesize the world’s information and learn how it evolves. We are developing a smart digital assistant software tool for professional investment managers. We are currently a team of 6 full-time employees, with diverse backgrounds; two mathematicians, three software engineers, and a business developer. Combined, we have strong experience with companies like Google, Medallia, Arctic Securities, Intelligent Trading, Microsoft, and Brain Corporation. We are located in Forskningsparken, by StartupLab. The company is well funded for several years of research, product development, and market launch.

Sky Labs is a norwegian company located in Trondheim. We deliver simple and user-friendly wireless guest network solutions to our customers.   Our solution gives customers increased ownership in their own guest networks by controlling bandwidth to users, maintain security and control of the network in terms of authentiseringstype and market themselves through a web portal at login.

På YouWish.no finner du Norges største utvalg av opplevelsesgaver. Sammen med landets beste arrangører tilbyr vi flere hundre opplevelsesgaver som du enkelt kan kjøpe i gave til de du er glad i. Med en opplevelsesgave gir du bort kvalitetstid og minner for livet. Vi er stolte av å tilby deg en platform der du trygt, enkelt og raskt kan gi bort minneverdige gaver til den som har alt.

Resoptima is a young technology company, experiencing rapid growth. We develop innovative software solutions, helping upstream oil and gas companies improve efficiency, understand risk and make better investment decisions. We operate in an international environment and have customers in all major regions. We have successful software solutions, clearly differentiated from alternative solutions. We have a proven track record of innovation, and several promising ideas in the pipeline. We have great offices, centrally located in Oslo.